Literature DB >> 158007

Lambda bacteriophage-mediated transduction of ColE1 deoxyribonucleic acid having a lambda bacteriophage-cohesive end site: selection of packageable-length deoxyribonucleic acid.

K Umene, K Shimada, T Tsuzuki, R Mori, Y Takagi.   

Abstract

An in vitro recombinant ColE1-cos lambda deoxyribonucleic acid (DNA) molecule, pKY96, has 70% of the length of lambda phage DNA. The process of lambda phage-mediated transduction of pKY96 generated a small amount of transducing phage particles containing ColE1-cos lambda DNA molecules of 80 or 101% of the length of lambda phage DNA, in addition to those containing original pKY96 DNA molecules. The newly isolated larger plasmid DNAs were transduced 100 times more efficiently than pKY96 DNA. Their structures were compared with that of a prototype pKY96 DNA, and the mechanism of the formation of these molecules is discussed.

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 158007      PMCID： PMC218017          DOI： 10.1128/jb.139.3.738-747.1979

Source DB:  PubMed          Journal:  J Bacteriol        ISSN： 0021-9193            Impact factor:   3.490


  21 in total

1.  Processing of bacteriophage lambda DNA during its assembly into heads.

Authors:  M Syvanen
Journal:  J Mol Biol       Date:  1975-01-15       Impact factor: 5.469

2.  Studies on the cleavage of bacteriophage lambda DNA with EcoRI Restriction endonuclease.

Authors:  M Thomas; R W Davis
Journal:  J Mol Biol       Date:  1975-01-25       Impact factor: 5.469

3.  In vitro construction of different oligomeric forms of lambdadv DNA and studies of their transforming activities.

Authors:  K Matsubara; Y Takagi; T Mukai
Journal:  J Virol       Date:  1975-09       Impact factor: 5.103

4.  DNA as substrate for packaging into bacteriophage lambda, in vitro.

Authors:  B Hohn
Journal:  J Mol Biol       Date:  1975-10-15       Impact factor: 5.469

5.  Packaging of ColE1 DNA having a lambda phage cohesive end site.

Authors:  K Umene; K Shimada; Y Takagi
Journal:  Mol Gen Genet       Date:  1978-02-07

6.  Replication of bacteriophage lambda DNA dependent on the function of host and viral genes. I. Interaction of red, gam and rec.

Authors:  L W Enquist; A Skalka
Journal:  J Mol Biol       Date:  1973-04-05       Impact factor: 5.469

7.  Prophage lambda at unusual chromosomal locations. I. Location of the secondary attachment sites and the properties of the lysogens.

Authors:  K Shimada; R A Weisberg; M E Gottesman
Journal:  J Mol Biol       Date:  1972-02-14       Impact factor: 5.469

8.  Construction of a colicin E1-R factor composite plasmid in vitro: means for amplification of deoxyribonucleic acid.

Authors:  T Tanaka; B Weisblum
Journal:  J Bacteriol       Date:  1975-01       Impact factor: 3.490

9.  Excision and duplication of su3+-transducing fragments carried by bacteriophage phi 80. I. Novel structure of phi 80sus2psu3+ DNA molecule.

Authors:  H Yamagishi; H Inokuchi; H Ozeki
Journal:  J Virol       Date:  1976-06       Impact factor: 5.103

10.  Viable molecular hybrids of bacteriophage lambda and eukaryotic DNA.

Authors:  M Thomas; J R Cameron; R W Davis
Journal:  Proc Natl Acad Sci U S A       Date:  1974-11       Impact factor: 11.205
View more
  4 in total

1.  Cosmid-based system for transient expression and absolute off-to-on transcriptional control of Escherichia coli genes.

Authors:  John E Cronan
Journal:  J Bacteriol       Date:  2003-11       Impact factor: 3.490

2.  Embryonic stem cell gene targeting using bacteriophage lambda vectors generated by phage-plasmid recombination.

Authors:  T Tsuzuki; D E Rancourt
Journal:  Nucleic Acids Res       Date:  1998-02-15       Impact factor: 16.971

3.  Improved plasmid-based system for fully regulated off-to-on gene expression in Escherichia coli: application to production of toxic proteins.

Authors:  John E Cronan
Journal:  Plasmid       Date:  2012-09-25       Impact factor: 3.466

4.  Production of highly knotted DNA by means of cosmid circularization inside phage capsids.

Authors:  Sonia Trigueros; Joaquim Roca
Journal:  BMC Biotechnol       Date:  2007-12-21       Impact factor: 2.563
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.